Navigation Links
Anti-Obesity Vaccine Successful In Rats

Researchers Kim Janda and her colleagues at the Scripps Research Institute in California developed three vaccinations against ghrelin//, a hormone that stimulates hunger and facilitates the storage of sugar as fat.

The effectiveness of the vaccine was tested in laboratory rats and the study results are published in the Journal Proceedings of the National Academy of Science. Further research and studies in this regard could offer clues that could lead to human treatment. It is a widely known fact that more than 1 billion people are suffering from obesity and that it contributes to other problems such as heart disease, various cancers, Type 2 diabetes, stroke, arthritis and depression. On the other hand drugs and other therapies have been largely unsuccessful.

This novel vaccine when administered on rats was found to be very effective. Ghrelin after reaching the CNS over long periods stimulates the retention of a level of stored energy as fat. The vaccine triggers the immune system to produce antibodies against the ghrelin. It was found that the animals that were vaccinated ate the same, drank the same, but their weight gain was slowed by a dramatic amount when compared to the one's that weren't vaccinated. Doctor Kim Janda said that though the vaccine is in its early experimental stages it could in the long run become a powerful weapon against obesity.


'"/>




Page: 1

Related medicine news :

1. Anti-Obesity Groups Criticize Response of Medical Professionals
2. Serotonin the Answer for Anti-Obesity Treatment
3. Robert Wood Johnson Foundation Pledges $500M To Fund Anti-Obesity Programs
4. Vaccine to quit smoking?
5. First Vaccine Designed for Africa Cleared for Testing in Humans
6. Vaccine for Alzheimer’s diseas
7. Health Officials Recommend Flu Vaccine
8. Smallpox Vaccine May Help Fight Cervical Cancer
9. Panacea Biotech To Market Anthrax Vaccine
10. New Prostate Cancer Vaccine Shows Promise
11. Drug Firm Offers to Donate Smallpox Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... ... 22, 2017 , ... Patients who avoid necessary dental and endodontic treatments because ... Kisco, NY from Advanced Endodontics of Westchester. This highly-trained team of endodontists offer three ... more sedation methods may be recommended based on the severity of the anxiety experienced ...
(Date:5/22/2017)... , ... May 22, 2017 , ... An inventor from ... with a pen. "My wife’s hand was damaged in a firework accident, so she ... helps people with manual problems." , He then designed and created a prototype for ...
(Date:5/22/2017)... ... May 22, 2017 , ... Faithfully following pop culture, people today are ... toned and shaped through fitness programs. It carries on to skin nourished, pampered and ... an irresistible, radiant smile. CDA has found that just like a perfectly ...
(Date:5/21/2017)... ... , ... Chris Cornell, 52, was found dead on the night of Wednesday, May 17, 2017. ... singers in the rock industry would take his own life, but the extremely talented and ... illness played a role in the death of Chris Cornell . , Depression and ...
(Date:5/21/2017)... Viejo, CA (PRWEB) , ... May 20, 2017 ... ... self-animating, paragraph styled corporate text designs created specifically for use in Final Cut ... editing process for all media productions. Pixel Film Studios’ ProParagraph Corporate will deliver ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... 22, 2017  As the specialty pharmacy industry ... to make the revolutionary shift from volume-based to ... ensuring positive patient outcomes and shaping the future ... focus away from clinical trials and toward data ... specialty drug therapy utilization in precise patient populations. ...
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
Breaking Medicine Technology: